Giovanni Zuliani

University of Ferrara — Italy

Medicine · Health Sciences

58h-index11.4kcitations384works4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(32), Alzheimer's disease research and treatments(32), Diabetes, Cardiovascular Risks, and Lipoproteins(31), Dementia and Cognitive Impairment Research(29), Nutrition and Health in Aging(26)

Publications377 total

The social microbiome of older people
Ageing Research Reviews·2025Open Access
Effectiveness of acetylcholinesterase inhibitors and memantine in patients affected by severe dementia
GeroScience·2025Open Access
Late-onset alzheimer’s disease, atherosclerosis, and cerebrovascular disease. A complex relationship too often neglected: a narrative review
Aging Clinical and Experimental Research·2025· 1 citedOpen Access
Sex-difference in the association between Triglyceride-Glucose (TyG) index and dementia
Journal of Diabetes & Metabolic Disorders·2025Open Access
Efficacy of Mediterranean diet for the prevention of neurological diseases: A systematic review and meta-analysis featured in the Italian National Guidelines “La Dieta Mediterranea”
Nutrition·2025· 2 citedOpen Access
Prevalence and clinical significance of loneliness in older patients admitted to acute hospital wards
The journal of nutrition health & aging·2025· 2 citedOpen Access
Advanced glycation end-product intake predicts insulin resistance in a sex-dependent fashion
European Journal of Nutrition·2025· 1 citedOpen Access
Iron deficiency anemia-related mortality trends in US older subjects, 1999 to 2019
Aging Clinical and Experimental Research·2025· 3 citedOpen Access
Serum β-secretase 1 (sBACE1) activity in subjective cognitive decline: an exploratory study
GeroScience·2025· 1 citedOpen Access
BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer’s Disease
Current Pharmaceutical Design·2025
Lezioni di Medicina Interna
IRIS UNIMORE (University of Modena and Reggio Emilia)·2025
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis
Neuromethods·2024
PON1 and PON3 in Alzheimer’s Disease: Similar Functions but Different Roles
Antioxidants·2024· 4 citedOpen Access
Serum Beta-Secretase 1 Activity Is a Potential Marker for the Differential Diagnosis between Alzheimer’s Disease and Frontotemporal Dementia: A Pilot Study
International Journal of Molecular Sciences·2024· 7 citedOpen Access
A case report of a probable drug-induced liver injury after therapy remodulation with lamotrigine, quetiapine and sertraline in an adult female with recurrent major depression using the updated RUCAM score
Psychiatry Research Case Reports·2024Open Access
High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia
Neurochemistry International·2024· 23 citedOpen Access
Cerebral Blood Flow in Alzheimer’s Disease: A Meta-Analysis on Transcranial Doppler Investigations
Geriatrics·2024· 5 citedOpen Access
Variability in Alzheimer’s disease mortality from European vital statistics, 2012–2020
International Journal of Geriatric Psychiatry·2024· 5 citedOpen Access
Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer’s disease
Aging Clinical and Experimental Research·2024· 30 citedOpen Access
Neutrophil–Lymphocytes Ratio as Potential Early Marker for Alzheimer’s Disease
Mediators of Inflammation·2024· 5 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

R. Fellin(24), Stefano Volpato(19), Stefania Bandinelli(11), Luigi Ferrucci(10), Jack M. Guralnik(9), Fulvio Lauretani(8), Antonio Cherubini(8), Amedeo Zurlo(8), Angelina Passaro(8), Alessandro Blè(6), Cristina Bosi(6), Carlo Cervellati(6), Marcello Arca(4), Gian Paolo Ceda(4), M.R. Munari(4), Margherita Cavalieri(4), Carmelinda Ruggiero(4), Arianna Romani(4), Davide Seripa(4), Marcello Maggio(4)